DCGI Dr Eswara Reddy, announces increasing validity of GMP Certificate from two to three years
Ministry of Commerce and Industry is fully committed to promoting the Indian pharmaceuticals industry globally including China, said Commerce and Industry Minister, Mr Suresh Prabhu, after inaugurating 'iPHEX' in New Delhi.
The 6th annual International Exhibition of Pharma and Healthcare (iPHEX) is being attended by over 650 delegates from 130 countries, including scores of regulators. The Minister said that Government is committed to promoting pharmaceutical exports to untapped markets, including China which has agreed for a high level bilateral Round Table meet to pave the way for Indian Pharma to get market access and penetration in their vast market. Regions like Latin America and Africa hold huge export potential for Indian pharmaceutical products.
Shri Prabhu assured the global pharmaceutical players and regulators, of best quality and affordability of the Indian drugs. He emphasised the need for reaching out to newer markets, especially in Africa, where affordability is the key issue, which can be very well addressed by the Indian exporters. He stressed on the need of both competitive and complementary strategies, so that each segment of Pharmaceutical sector can benefit. There is need to make both traditional and preventive medicine, to work together. Genomics is the new branch in medicine, which can play a major role for the Indian Pharmaceutical sector. Make more investments in R&D activities so that the pipeline (for new medicines) do not get dry. Research and development investments will boost domestic growth.
Speaking on the occasion, Commerce Secretary Mrs Rita Teaotia said that effort is on to ensure uniform quality in the pharmaceutical sector. The Ministry is committed to ensure that consistent quality and efficacy is maintained by Indian pharmaceutical products. The market size of the global pharma industry is over $1 trillion and it holds huge potential for countries like India. We have to make healthcare affordable.
Enumerating the measures to improve Ease of Doing Business, the Drugs Controller General of India, Dr Eswara Reddy, announced increasing the validity of the GMP (Good Manufacturing Practices) Certificate, from two to three years. He further stated that protocol for clinical trials approval has also been changed, setting the time line of 45 days. Once approval does not come within this timeline, the protocol would have deemed to be approved.The move would help reduce delay in the registration process and promote exports, he said, adding that applications are now processed and approved online.
Chairman of the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) Mr Madan Mohan Reddy expressed confidence that the global business will be retained in India because of competitive cost of production. He complimented the Commerce and Industry Ministry for taking several measures to make India the main source of global manufacturing in pharmaceuticals. PHARMEXCIL Vice Chairman Mr Dinesh Dua said besides generics, India will soon emerge as a force to reckon with in the area of innovative drugs.
Snaps from the event:
Guest of Honour Ms. Rita Teaotia, Commerce Secretary, Department of Commerce, Govt of India presented the theme address at #IPHEX2018.
Dr. S E Reddy, DCG(I), Ministry of Health & Family Welfare, Govt of India delivers the address on ‘Ensuring Quality & Compliance Conformity in Pharmaceuticals in India’ at #IPHEX2018.
Mr. @shyamalmisra, IAS, Joint Secretary, Department of Commerce, Govt of India gives the special address at #IPHEX2018.
Dr. Dinesh Dua, Chairman-IPHEX Vice Chairman, Pharmexcil presented the opening remarks at #IPHEX2018
Commerce Secretary Ms. Rita Teaotia inaugurated the Exhibition on Pharma & Healthcare being held at Pragati Maidan, New Delhi.
Stall of Accuprec Research Labs Pvt Ltd @ iPHEX 2018